FGFR inhibitor induced peripheral neuropathy in patients with advanced RCC

Ann Oncol. 2010 Jul;21(7):1559-1560. doi: 10.1093/annonc/mdq237. Epub 2010 May 5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Benzimidazoles / adverse effects*
  • Carcinoma, Renal Cell / complications*
  • Carcinoma, Renal Cell / drug therapy
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase III as Topic
  • ErbB Receptors / antagonists & inhibitors*
  • ErbB Receptors / metabolism
  • Humans
  • Kidney Neoplasms / complications*
  • Kidney Neoplasms / drug therapy
  • Male
  • Middle Aged
  • Peripheral Nervous System Diseases / chemically induced*
  • Peripheral Nervous System Diseases / drug therapy
  • Quinolones / adverse effects*
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
  • Benzimidazoles
  • Quinolones
  • EGFR protein, human
  • ErbB Receptors